Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Linezolid was approved in 2000 for treatment of gram-positive coccal infections. We performed a case-control study during a hospital outbreak of linezolid-resistant enterococci (LRE) infections, comparing cases of LRE infection (cases) with linezolid-sensitive enterococci infections (controls). Nasa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kainer, Marion A., Devasia, Rose A., Jones, Timothy F., Simmons, Bryan P., Melton, Kelley, Chow, Susan, Broyles, Joyce, Moore, Kelly L., Craig, Allen S., Schaffner, William
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878236/
https://www.ncbi.nlm.nih.gov/pubmed/18214174
http://dx.doi.org/10.3201/eid1307.070019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878236/
https://www.ncbi.nlm.nih.gov/pubmed/18214174
http://dx.doi.org/10.3201/eid1307.070019

Ejemplares similares